These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28922805)

  • 1. Failure of the azithromycin and ethambutol combination regimen in the hollow-fibre system model of pulmonary Mycobacterium avium infection is due to acquired resistance.
    Srivastava S; Deshpande D; Gumbo T
    J Antimicrob Chemother; 2017 Sep; 72(suppl_2):i20-i23. PubMed ID: 28922805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 'shock and awe' thioridazine and moxifloxacin combination-based regimen for pulmonary Mycobacterium avium-intracellulare complex disease.
    Srivastava S; Deshpande D; Sherman CM; Gumbo T
    J Antimicrob Chemother; 2017 Sep; 72(suppl_2):i43-i47. PubMed ID: 28922810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease.
    Deshpande D; Srivastava S; Pasipanodya JG; Lee PS; Gumbo T
    J Antimicrob Chemother; 2017 Sep; 72(suppl_2):i48-i53. PubMed ID: 28922809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent Treatment with Azithromycin and Ethambutol for Noncavitary Mycobacterium avium Complex Pulmonary Disease.
    Moon SM; Yoo IY; Huh HJ; Lee NY; Jhun BW
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
    Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
    Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standard therapy of Mycobacterium avium complex pulmonary disease shows limited efficacy in an open source hollow fibre system that simulates human plasma and epithelial lining fluid pharmacokinetics.
    Ruth MM; Raaijmakers J; van den Hombergh E; Aarnoutse R; Svensson EM; Susanto BO; Simonsson USH; Wertheim H; Hoefsloot W; van Ingen J
    Clin Microbiol Infect; 2022 Mar; 28(3):448.e1-448.e7. PubMed ID: 34332109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
    Jeong BH; Jeon K; Park HY; Kim SY; Lee KS; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Am J Respir Crit Care Med; 2015 Jan; 191(1):96-103. PubMed ID: 25393520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tedizolid is highly bactericidal in the treatment of pulmonary Mycobacterium avium complex disease.
    Deshpande D; Srivastava S; Pasipanodya JG; Lee PS; Gumbo T
    J Antimicrob Chemother; 2017 Sep; 72(suppl_2):i30-i35. PubMed ID: 28922807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium.
    Ward TT; Rimland D; Kauffman C; Huycke M; Evans TG; Heifets L
    Clin Infect Dis; 1998 Nov; 27(5):1278-85. PubMed ID: 9827282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of rifampicin within the treatment of
    Schildkraut JA; Raaijmakers J; Aarnoutse R; Hoefsloot W; Wertheim HFL; van Ingen J
    Antimicrob Agents Chemother; 2023 Nov; 67(11):e0087423. PubMed ID: 37877693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model.
    Bermudez LE; Nash KA; Petrofsky M; Young LS; Inderlied CB
    J Infect Dis; 1996 Dec; 174(6):1218-22. PubMed ID: 8940212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarecycline pharmacokinetics/pharmacodynamics in the hollow-fibre model of Mycobacterium avium complex: so near and yet so far.
    Singh S; Boorgula GD; Aryal S; Philley JV; Gumbo T; Srivastava S
    J Antimicrob Chemother; 2024 Jan; 79(1):96-99. PubMed ID: 37946564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability Outcomes of American Thoracic Society/Infectious Diseases Society of America Guideline-Recommended Multidrug Antibiotic Treatment for Mycobacterium avium Complex Pulmonary Disease in US Medicare Beneficiaries With Bronchiectasis.
    Ku JH; Henkle E; Carlson KF; Marino M; Brode SK; Marras TK; Winthrop KL
    Chest; 2024 May; 165(5):1058-1069. PubMed ID: 38086472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clofazimine as a substitute for rifampicin improves efficacy of
    Salillas S; Raaijmakers J; Aarnoutse RE; Svensson EM; Asouit K; van den Hombergh E; Te Brake L; Stemkens R; Wertheim HFL; Hoefsloot W; van Ingen J
    Antimicrob Agents Chemother; 2024 Mar; 68(3):e0115723. PubMed ID: 38259101
    [No Abstract]   [Full Text] [Related]  

  • 15. Linezolid as treatment for pulmonary Mycobacterium avium disease.
    Deshpande D; Srivastava S; Pasipanodya JG; Gumbo T
    J Antimicrob Chemother; 2017 Sep; 72(suppl_2):i24-i29. PubMed ID: 28922806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between Resistance to Ethambutol and Rifampin and Clinical Outcomes in Mycobacterium avium Complex Pulmonary Disease.
    Moon SM; Kim SY; Kim DH; Huh HJ; Lee NY; Jhun BW
    Antimicrob Agents Chemother; 2022 Apr; 66(4):e0202721. PubMed ID: 35266825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection.
    Chaisson RE; Keiser P; Pierce M; Fessel WJ; Ruskin J; Lahart C; Benson CA; Meek K; Siepman N; Craft JC
    AIDS; 1997 Mar; 11(3):311-7. PubMed ID: 9147422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of oral antimycobacterials and dosing guidance for Mycobacterium avium complex treatment in cystic fibrosis.
    Martiniano SL; Wagner BD; Brennan L; Wempe MF; Anderson PL; Daley CL; Anthony M; Nick JA; Sagel SD
    J Cyst Fibros; 2021 Sep; 20(5):772-778. PubMed ID: 34030986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thioridazine as Chemotherapy for Mycobacterium avium Complex Diseases.
    Deshpande D; Srivastava S; Musuka S; Gumbo T
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4652-8. PubMed ID: 27216055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy.
    Ito Y; Miwa S; Shirai M; Kanai M; Fujita K; Ohba H; Iwaizumi E; Oshima T; Kojima S; Suda T; Hayakawa H
    Respir Med; 2020 Aug; 169():106025. PubMed ID: 32442113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.